Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.
The University of Alabama at Birmingham – $100,000
$100,000.00
December 2023
Intranasal Delivery of Targeting Nanotherapeutics for DIPG
Funding of PBTCF 2023 - $25,000
$25,000.00
December 2023
Children's Cancer Institute – $181,736 USD, $281,691 AUD
$181,736.00
November 2023
Targeting post-translational protein modification to halt Diffuse Intrinsic Pontine Glioma tumorgenicity
Memorial Sloan Kettering Cancer Center – $100,000
$100,000.00
November 2023
CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors
University of Colorado Denver – $200,000
$200,000.00
November 2023
Preclinical assessment of efficacy and specificity of logic-gated CAR-T cell therapy in Diffuse Intrinsic Pontine Glioma
SIOPe DIPG/DMG Registry – $715,852 USD, € 643,014
$715,852.00
November 2023
Renewal of the European DIPG/DMG Registry
Cincinnati Children's Hospital – $200,000
$200,000.00
November 2023
Targeting diffuse midline gliomas with innovative T cell immunotherapy
Cincinnati Children's Hospital – $50,000
$50,000.00
May 2023
Exploring Novel Targets In DIPG
University Medicine Göttingen – $50,000
$50,000.00
May 2023
Starve the monster: Multi-metabolic treatment strategies for H3.3K27M-mutant DIPG/DMG
Funding of PBTCF 2023 - $25,000
$25,000.00
January 2023
University of Queensland Diamantina Institute – $100,000
$100,000.00
November 2022
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Erasmus University Medical Center – $432,354
$432,354.00
November 2022
Development and optimization of targeted radiopharmaceutical therapies for pediatric brain tumors; a world-first translational study. Acronym: TARGET-FIRST
Cincinnati Children's Hospital Medical Center – $60,000
$60,000.00
November 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital Medical Center – $153,867
$153,867.00
November 2022
Combining innovative proton radiotherapy with targeted and immune therapies to treat DMG/DIPG
Hunter Medical Research Institute – $232,932
$232,932.00
November 2022
Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies